Key result
Troponin I R21C mutation reduces LV force versus RV in mice, linked to RLC phosphorylation.
Why the study?
Does the R21C mutation in cardiac troponin I alter contractile force generation and myofilament protein phosphorylation in the left and right ventricles of knock-in mice?
Does the R21C mutation in cardiac troponin I alter contractile force generation and myofilament protein phosphorylation in the left and right ventricles of knock-in mice?
Answers are grounded in this paper and cite their sources.
The R21C mutation in cardiac troponin I causes differential contractile force generation and myosin regulatory light chain phosphorylation between the left and right ventricles in a mouse model of hypertrophic cardiomyopathy.
We investigated the effect of the hypertrophic cardiomyopathy-linked R21C (arginine to cysteine) mutation in human cardiac troponin I (cTnI) on the contractile properties and myofilament protein phosphorylation in papillary muscle preparations from left (LV) and right (RV) ventricles of homozygous R21C(+/+) knock-in mice. The maximal steady-state force was significantly reduced in skinned papillary muscle strips from the LV compared to RV, with the latter displaying the level of force observed in LV or RV from wild-type (WT) mice. There were no differences in the Ca(2+) sensitivity between the RV and LV of R21C(+/+) mice; however, the Ca(2+) sensitivity of force was higher in RV-R21C(+/+) compared with RV-WT and lower in LV- R21C(+/+) compared with LV-WT. We also observed partial loss of Ca(2+) regulation at low [Ca(2+)]. In addition, R21C(+/+)-KI hearts showed no Ser23/24-cTnI phosphorylation compared to LV or RV of WT mice. However, phosphorylation of the myosin regulatory light chain (RLC) was significantly higher in the RV versus LV of R21C(+/+) mice and versus LV and RV of WT mice. The difference in RLC phosphorylation between the ventricles of R21C(+/+) mice likely contributes to observed differences in contractile force and the lower tension monitored in the LV of HCM mice.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2015) studied Hypertrophic cardiomyopathy. R21C(+/+) mutation in cardiac troponin I vs. Wild-type (WT) mice was evaluated on Contractile properties and myofilament protein phosphorylation in papillary muscle preparations. The R21C mutation in cardiac troponin I reduced maximal steady-state force in the left ventricle compared to the right ventricle of knock-in mice, linked to differences in RLC phosphorylation.
Synapse has enriched 10 related papers. Consider them for comparative context: